| Stage | NI | % of rev | CNP | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $1.3B | 100.00% | $2.2B | 100.00% | CNP ×1.62 |
| Gross profit | $714M | 52.88% | $1.3B | 57.33% | CNP +4.4pp |
| Operating income | $340M | 25.22% | $667M | 30.44% | CNP +5.2pp |
| Pre-tax income | $152M | 11.27% | $413M | 18.85% | CNP +7.6pp |
| Net income | $139M | 10.30% | $331M | 15.11% | CNP +4.8pp |
| Stage | NI | CNP | Gap · A − B |
|---|---|---|---|
| Revenue | $1.3B100.00% | $2.2B100.00% | CNP ×1.62 |
| Gross profit | 52.88%$714M | 57.33%$1.3B | CNP +4.4pp |
| Operating income | 25.22%$340M | 30.44%$667M | CNP +5.2pp |
| Pre-tax income | 11.27%$152M | 18.85%$413M | CNP +7.6pp |
| Net income |
| 10.30%$139M |
| 15.11%$331M |
| CNP +4.8pp |
No shared counterparties.